Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

23andMe Holding Co.

ME•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.61
$0.00(0.00%)
U.S. Market opens in 12h 22m

23andMe Holding Co. (ME) Stock Overview

Explore 23andMe Holding Co.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.3M
P/E Ratio-0.07
EPS (TTM)$-17.39
ROE-5.52%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.02
3 Months$0.00
1 Year Target$0.00

ME Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 23andMe Holding Co. (ME) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.07 and a market capitalization of 15.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-73.75%
3-Year Change
-98.83%
5-Year Change
-99.73%
All-Time (Max) Change
-99.69%

Contact Information

https://www.23andme.com
650 938 6300
349 Oyster Point Boulevard, South San Francisco, CA, 94080

Company Facts

5,600 Employees
IPO DateNov 23, 2020
CountryUS

Frequently Asked Questions